Wellington Management Group
JANX icon

Wellington Management Group’s Janux Therapeutics JANX Stock Holding History

Wellington Management Group’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.2M Sell
1,507,360
-90,290
-6% -$1.31M ﹤0.01% 1013
2026
Q1 		$22.2M Sell
1,597,650
-12,536
-0.8% -$172K ﹤0.01% 963
2025
Q4 		$22.2M Buy
1,610,186
+908,582
+130% +$21.4M ﹤0.01% 999
2025
Q3 		$17.1M Buy
701,604
+209,243
+42% +$5.1M ﹤0.01% 1088
2025
Q2 		$11.4M Buy
492,361
+98,884
+25% +$2.61M ﹤0.01% 1172
2025
Q1 		$10.6M Sell
393,477
-141,919
-27% -$5.35M ﹤0.01% 1188
2024
Q4 		$28.7M Buy
535,396
+520,898
+3,593% +$27.6M 0.01% 870
2024
Q3 		$659K Sell
14,498
-29,436
-67% -$1.28M ﹤0.01% 1779
2024
Q2 		$1.84M Buy
43,934
+12,339
+39% +$579K ﹤0.01% 1539
2024
Q1 		$1.19M Buy
+31,595
New +$688K ﹤0.01% 1643
2021
Q3 		– Sell
-9,165
Closed -$229K – 2207
2021
Q2 		$229K Buy
+9,165
New +$204K ﹤0.01% 2073

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Wellington Management Group's JANX Position: Q2 2026 in Review

Wellington Management Group reduced its Janux Therapeutics (JANX) stake by 5.7% in Q2 2026, selling an estimated $1.31M and leaving 1,507,360 shares worth $23.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1013.

Wellington Management Group first reported a position in JANX in Q2 2021 and has held it in 11 quarters since. The position peaked at $28.7M in Q4 2024. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Wellington Management Group held 1,507,360 shares of Janux Therapeutics worth $23.2M as of Q2 2026.
  • Wellington Management Group sold 90,290 Janux Therapeutics shares in Q2 2026, an estimated $1.31M.
  • Janux Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1013 holding.
  • Wellington Management Group first reported a position in Janux Therapeutics in Q2 2021 and has held it in 11 quarters since.
  • Wellington Management Group's Janux Therapeutics position peaked at $28.7M in Q4 2024.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.